Company profile AFMD
There is not enough data for Affimed N.V. to provide analysis
There is not enough data for Affimed N.V. to provide correlation calculation
There is not enough data for Affimed N.V. to provide analysis
After 39 days of this quarter the interest is at 79.0. Based on that we can calculate that during remaining 52 days it will total up to 184.0. AFMD stock expected interest is significantly higher compared to previous quarter (+47.2%) and same quarter last year (+49.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 206 | 225 9.2% QoQ | 132 -41.3% QoQ | 110 -16.7% QoQ |
| 2020 | 162 -21.4% YoY 47.3% QoQ | 192 -14.7% YoY 18.5% QoQ | 155 17.4% YoY -19.3% QoQ | 284 158.2% YoY 83.2% QoQ |
| 2021 | 248 53.1% YoY -12.7% QoQ | 508 164.6% YoY 104.8% QoQ | 174 12.3% YoY -65.7% QoQ | 184 -35.2% YoY 5.7% QoQ |
| 2022 | 137 -44.8% YoY -25.5% QoQ | 158 -68.9% YoY 15.3% QoQ | 60 -65.5% YoY -62.0% QoQ | 94 -48.9% YoY 56.7% QoQ |
| 2023 | 123 -10.2% YoY 30.9% QoQ | 107 -32.3% YoY -13.0% QoQ | 83 38.3% YoY -22.4% QoQ | 125 33.0% YoY 50.6% QoQ |
| 2024 | 79 -35.8% YoY -36.8% QoQ | - | - | - |
The average 5 years interest of AFMD stock was 13.59 per week. The last year interest of AFMD stock compared to the last 5 years has changed by -32.08%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -36.17%.
There is not enough data for AFM13 clinical trial to provide analysis
There is not enough data for AFM13 clinical trial to provide correlation calculation
There is not enough data for AFM13 clinical trial to provide analysis
There is not enough data for AFM24 clinical trial to provide analysis
There is not enough data for AFM24 clinical trial to provide correlation calculation
There is not enough data for AFM24 clinical trial to provide analysis
After 34 days of this quarter the interest is at 310.0. Based on that we can calculate that during remaining 58 days it will total up to 839.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 493 |
| 2019 | 730 48.1% QoQ | 709 -2.9% QoQ | 661 -6.8% QoQ | 658 33.5% YoY -0.5% QoQ |
| 2020 | 690 -5.5% YoY 4.9% QoQ | 578 -18.5% YoY -16.2% QoQ | 604 -8.6% YoY 4.5% QoQ | 559 -15.0% YoY -7.5% QoQ |
| 2021 | 610 -11.6% YoY 9.1% QoQ | 635 9.9% YoY 4.1% QoQ | 626 3.6% YoY -1.4% QoQ | 670 19.9% YoY 7.0% QoQ |
| 2022 | 764 25.2% YoY 14.0% QoQ | 843 32.8% YoY 10.3% QoQ | 769 22.8% YoY -8.8% QoQ | 735 9.7% YoY -4.4% QoQ |
| 2023 | 827 8.2% YoY 12.5% QoQ | 806 -4.4% YoY -2.5% QoQ | 785 2.1% YoY -2.6% QoQ | 310 -57.8% YoY -60.5% QoQ |
The average 5 years interest of Cancer immunotherapy was 53.88 per week. The last year interest of Cancer immunotherapy compared to the last 5 years has changed by 12.75%. The interest for Cancer immunotherapy is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 12.46%.
After 39 days of this quarter the interest is at 273.0. Based on that we can calculate that during remaining 52 days it will total up to 637.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 419 | 598 42.7% QoQ | 538 -10.0% QoQ | 603 12.1% QoQ |
| 2020 | 688 64.2% YoY 14.1% QoQ | 633 5.9% YoY -8.0% QoQ | 510 -5.2% YoY -19.4% QoQ | 475 -21.2% YoY -6.9% QoQ |
| 2021 | 665 -3.3% YoY 40.0% QoQ | 494 -22.0% YoY -25.7% QoQ | 418 -18.0% YoY -15.4% QoQ | 532 12.0% YoY 27.3% QoQ |
| 2022 | 521 -21.7% YoY -2.1% QoQ | 546 10.5% YoY 4.8% QoQ | 685 63.9% YoY 25.5% QoQ | 565 6.2% YoY -17.5% QoQ |
| 2023 | 676 29.8% YoY 19.6% QoQ | 486 -11.0% YoY -28.1% QoQ | 586 -14.5% YoY 20.6% QoQ | 532 -5.8% YoY -9.2% QoQ |
| 2024 | 273 -59.6% YoY -48.7% QoQ | - | - | - |
The average 5 years interest of Biotechnology companies was 43.84 per week. The last year interest of Biotechnology companies compared to the last 5 years has changed by -0.55%. The interest for Biotechnology companies is seasonal. The last year interest is comparable to 5 years ago. It has changed only by -5.65%.
There is not enough data for Affimed N.V. investors to provide analysis
There is not enough data for Affimed N.V. investors to provide correlation calculation
There is not enough data for Affimed N.V. investors to provide analysis
There is not enough data for Affimed N.V. Germany to provide analysis
There is not enough data for Affimed N.V. Germany to provide correlation calculation
There is not enough data for Affimed N.V. Germany to provide analysis
There is not enough data for Affimed N.V. news to provide analysis
There is not enough data for Affimed N.V. news to provide correlation calculation
There is not enough data for Affimed N.V. news to provide analysis
There is not enough data for Affimed N.V. career to provide analysis
There is not enough data for Affimed N.V. career to provide correlation calculation
There is not enough data for Affimed N.V. career to provide analysis